In higher eukaryotes, a vast variety of RNAs is transcribed from genomic DNAs. The transcribed RNAs are subjected to RNA processing steps, such as splicing, ...

UC Irvine scientists developed bioluminescent RNA tags, "tiny guiding lights," using luciferase to track RNA in real-time, ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

The biggest milestone was the approval of Casgevy, a CRISPR-based therapy for sickle cell anemia and beta-thalassemia. We now have the first FDA-approved treatment that can permanently modify ...

The Best Gifts for Chess Players, According to Chess PlayersWe asked chess players, coaches, grandmasters, and world champions about their favorite things to give to folks like themselves. 33 ...

As CRISPR Therapeutics (CRSP) prepares to release its first-quarter 2025 earnings report, investors are eagerly anticipating insights into the performance of its sole-marketed product, Casgevy, and ...

This revolution is being powered by RNA technology — and Canada is uniquely positioned to lead it. While the swift development of COVID-19 vaccines appeared to be a sudden scientific triumph ...

Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (exagamglogene ... and messenger RNA (mRNA). The company's scope of CDMO services comprises process ...

Vertex and partner CRISPR Therapeutics’ CRSP one-shot gene therapy, Casgevy, was approved in late 2023/early 2024 for two blood disorders — sickle cell disease and transfusion-dependent beta ...

For more twisty quests full of excitement and intrigue, check out our Canvas the Castle Quest guide, or our map of every Deadric Artifact location in Oblivion Remastered. UPDATE: I see your ...

Welcome to our weekly PGA Tour gambling-tips column, featuring picks from GOLF.com’s expert prognosticator Brady Kannon. A seasoned golf bettor and commentator, Kannon is a regular guest on ...

Investing in the specialist workforce and overcoming access barriers is essential to successful delivery of this therapy in the NHS, write Jessie Enakhumhe and Yasmin Sheikh Casgevy, or exagamglogene ...